This work was supported by grants from the Natural Science Foundation of Guangdong Province (2023A1515012187, 2024A1515030281), Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases (2022B121203003), Discipline Construction Project of Guangdong Medical University (4SG21229G), Zhanjiang City Science and Technology Development Special Funds Competitive Allocation Project (2021A05083), Zhanjiang Science and Technology Project (2019A01027), National Clinical Key Specialty Construction Project (Institute of Nephrology, Affiliated Hospital of Guangdong Medical University), The Affiliated Hospital of Guangdong Medical University funded the research of high-level talents (10403Z20180001)
Drug delivery systems and materials for wound healing applications
C th: Tr em t 6 - 8 tui: 900mg/1 ngy T 90 - 13 tui: 1000 - 1200mg/1 ngy T 14 - 18 tui: 1100 - 1600mg/1 ngy Ph n mang thai: 1400mg/ngy Ph n cho con b: 1300mg/1 ngy Ngi trung nin v ngi gi: 1100mg/1 ngy Tuy nhin, khi b sung Omega 3, chng ta cn ch n hm lng EPA v DHA c b sung hn l Omega 3
91 It is unclear whether the heart rate increase associated with GLP-1 RAs, which may pose a safety concern in patients with HFrEF, can be mitigated by the concurrent use of -blockers, which are typically prescribed for HFrEF
